Supreme Court extends mifepristone deadline

• by Theresa Gaffney

• May 12, 2026

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

• by Kathryn Wighton

• April 1, 2026

• 2 min

Clinical efficacy of acupuncture for women with PCOS undergoing IVF/ICSI: a meta-analysis of randomized controlled trials

• by Shanshan Guo, Hong Xia, Weihong Yang, Guangyao Lin, Qianjue Tang, Lianwei Xu

• May 29, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min